Porous HDPE Composition for Flexible Maxillofacial Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
High density polyethylene polymers face limited success in producing maxillofacial implants due to the need for unique properties such as porosity and mechanical flexibility, which are not adequately addressed by existing orthopedic implant technologies.
Innovation Solution
A high density polyethylene polymer composition with a broad particle size distribution, including coarse and small particles, is formulated to produce a porous structure that facilitates vascular ingrowth and provides excellent mechanical properties, suitable for maxillofacial implants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If high density polyethylene polymer is used for orthopedic implants, then mechanical strength and durability are improved, but porosity and flexibility required for maxillofacial implants are insufficient
Solution Approach 1:
The patent changes the particle size distribution parameter of the polyethylene polymer from conventional narrow distributions to broad distributions ranging from 45 microns to 2.5 mm, with specific emphasis on including coarse particles (1.0-2.5 mm) and fine particles (15-45 microns). This parameter change enables the molded article to achieve both adequate mechanical strength and the required porosity for maxillofacial implant applications
Solution Approach 2:
The patent creates a composite-like structure within the polyethylene material by combining particles of vastly different sizes (from 45 microns to 2.5 mm) in a single polymer composition. This multi-size particle composite approach allows the material to exhibit both the strength characteristics of densely packed regions and the porosity characteristics of regions with larger inter-particle voids
2Manufacturing precision
If conventional polyethylene polymer with narrow particle size distribution is used, then manufacturing consistency is improved, but porous structure formation for vascular ingrowth is insufficient
Solution Approach 1:
The patent deliberately changes the particle size distribution parameter from narrow to broad, specifying a range from 45 microns to 2.5 mm with d50 between 0.3-1.0 mm. This parameter change is controlled and consistent, ensuring manufacturing precision while simultaneously enabling reliable porous structure formation that supports vascular ingrowth in maxillofacial implants
3Ease of operation
If polyethylene polymer is molded for maxillofacial implants, then implant flexibility is improved, but adequate porosity for bony ingrowth is insufficient
Solution Approach 1:
The patent employs a composite particle structure combining fine particles (15-45 microns) that provide flexibility and cohesiveness with coarse particles (1.0-2.5 mm) that create porosity. This composite approach at the particle level translates to the macroscopic level, enabling the molded implant to simultaneously achieve the flexibility needed for surgical handling and the porosity required for bony ingrowth
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer composition enables the production of maxillofacial implants with a porous structure that promotes bony ingrowth and flexibility, meeting the unique requirements of cranial and facial implants.
Implementation Method 1
When molded or sintered into an article, the polymer composition of the present disclosure produces a porous structure that is well suited for facilitating vascular ingrowth
Data Source
AI summary
A biocompatible polymer composition is disclosed comprised of high density polyethylene particles. The high density polyethylene particles when sintered into an article can promote vascular growth. For example, when molded into an article, the particles produce a porous structure particularly well suited for maxillofacial implants.